Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients

Clinical trial NCT00675103 · COMPLETED

Trial details

NCT number: NCT00675103
Sponsor: Savient Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Gout Refractory to Conventional Therapy

Start date: 2008-05-01
Primary completion: 2009-01-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.